Search

Your search keyword '"C. Berkowski"' showing total 29 results

Search Constraints

Start Over You searched for: Author "C. Berkowski" Remove constraint Author: "C. Berkowski"
29 results on '"C. Berkowski"'

Search Results

1. Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

2. Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms

3. RAVs Datenbank: Untersuchung der Häufigkeit und Charakteristika von RAVs bei therapienaiven und DAA-erfahrenen Patienten

5. Genotypen-spezifische Prävalenz und Bedeutung natürlich vorkommender Precore-, Basal Core Promotor- und preS-Mutationen in einer großen europäischen Studienkohorte bei chronisch mit dem Hepatitis B Virus infizierten Patienten

9. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection

11. P0721 : Viral and host parameters in association with outcome of acute hepatitis C in HIV-coinfected patients

12. P0766 : Epidemiology of viral resistance in genotype 1 infected patients at approval of IFN-free DAA combination therapy of chronic hepatitis C in Germany

13. Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy

14. European Ravs Database: Frequency and Characteristics of Ravs in Treatment-Naïve and DAA-Experienced Patients

15. Direct Antiviral Combination Treatment According to Presence of Baseline Ravs in NS3, NS5A and NS5B Leads to High SVR Rates in Non-Cirrhotic and Cirrhotic Genotype 1 Infected Patients

16. Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

19. P0818 : Analysis of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy

20. P0877 : HCVRNA levels assessed at early stages of sofosbuvir/ribavirin dual therapy identify relapse patients

21. Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection

22. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.

23. Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms.

24. Investigation of NS3 Protease Resistance-Associated Variants and Phenotypes for the Prediction of Treatment Response to HCV Triple Therapy.

25. Applicability of Hepatitis C Virus RNA Viral Load Thresholds for 8-Week Treatments in Patients With Chronic Hepatitis C Virus Genotype 1 Infection.

26. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.

27. Evolution and function of the HCV NS3 protease in patients with acute hepatitis C and HIV coinfection.

28. Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.

29. Variations in serum sphingolipid levels associate with liver fibrosis progression and poor treatment outcome in hepatitis C virus but not hepatitis B virus infection.

Catalog

Books, media, physical & digital resources